Therapeutic Asset Ratings
1,055 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Hydroxyurea
Ischemic Stroke
Vanderbilt University Medical Center
P2/3
B
(57)
Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 ?1-chain), disulfide with human-Mus musculus monoclonal JMT101 ?-chain, dimer
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.
P2/3
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Gallbladder Cancer
Cancer Research UK
P2/3
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Lung Neoplasm
Cancer Research UK
P2/3
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Prostate Neoplasm
Cancer Research UK
P2/3
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Tumor Of Salivary Gland
Cancer Research UK
P2/3
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Skin Neoplasm
Cancer Research UK
P2/3
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Urinary Bladder Neoplasm
Cancer Research UK
P2/3
B
(57)
Immunoglobulin G1 [de-449-lysine], anti-(human tau protein) (human-Mus musculus monoclonal E2814 ?1-chain), disulfide with human-Mus musculus monoclonal E2814 .kappa.-chain, dimer
Familial Alzheimer Disease
Washington University School of Medicine
P2/3
B
(57)
immunoglobulin G1-kappa, anti-[Homo sapiens MSTN (myostatin, growth differentiation factor 8, GDF8, GDF-8) latent myostatin complex], humanized monoclonal antibody;
Spinal Muscular Atrophy
Hoffmann-La Roche
P2/3
B
(57)
ip-001
Rectal Cancer
Immunophotonics, Inc.
P2/3
B
(57)
Ipilimumab
Adenosquamous Lung Carcinoma
National Cancer Institute (NCI)
P2/3
B
(57)
Itraconazole
Secondary Malignant Neoplasm
Gynaecologisch Oncologisch Centrum Zuid
P2/3
B
(57)
LENVATINIB
Disease Related To Solid Organ Transplantation
RenJi Hospital
P2/3
B
(57)
Letrozole
Atypical Endometrial Hyperplasia
Xiaojun Chen
P2/3
B
(57)
Letrozole
Inflammatory Breast Carcinoma
RenJi Hospital
P2/3
B
(57)
Letrozole
Breast Mucinous Carcinoma
RenJi Hospital
P2/3
B
(57)
Letrozole
Progesterone Resistance
Xiaojun Chen
P2/3
B
(57)
Letrozole
Secondary Malignant Neoplasm
Gynaecologisch Oncologisch Centrum Zuid
P2/3
B
(57)
Letrozole
Invasive Tubular Breast Carcinoma
RenJi Hospital
P2/3
B
(57)
Levonorgestrel
Atypical Endometrial Hyperplasia
Xiaojun Chen
P2/3
B
(57)
Levonorgestrel
Infertility Disorder
Xiaojun Chen
P2/3
B
(57)
Lisaftoclax
Acute Promyelocytic Leukemia
The Affiliated People's Hospital of Ningbo University
P2/3
B
(57)
lns8801
Melanoma
Linnaeus Therapeutics, Inc.
P2/3
B
(57)
Magnesiocard
Non-Small Cell Lung Carcinoma
Swiss Cancer Institute
P2/3
B
(57)
Showing 551 to 575 of 1,055 assets
Previous
Page 23 of 43
Next
